Public Health Trace

Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,239

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,844

Class I recallsReasonable probability of serious health consequences

24,383

Class II recallsTemporary or medically reversible health consequences

2,897

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,084 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/eden-brothers-recalls-calabrese-broccoli-seeds-due-possible-salmonella-contaminationPublished October 7, 2026

Most affected stateHawaii 200 recalls mention this state

State: IL ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated October 8, 2026 ET

Summary (Year to date)

1,739 recalls have been announced year to date.
Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
The highest complete period was Jun 2026 (300).
Oct 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,383
Class I	9,844
Class III	2,897
Not Yet Classified	2

Recalls by class
Class	Recalls
Class II	24,383
Class I	9,844
Class III	2,897
Not Yet Classified	2

FDA Recall TerminatedTerminated: April 11, 2017Historical recordClass II

Fluorouracil Topical Cream USP, 5%, 40 g Tube, Rx only, Mfd. by: Taro Pharmaceutical Industries, Ltd. Haifa Bay, Israel 26110, Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532, NDC 51672-4118-6.

by Taro Pharmaceuticals U.S.A., Inc.

Reason: Product Lacks Stability: Out-of-specification (OOS) results were observed for assay and description in retain samples.
Published: December 12, 2012
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: November 14, 2013Historical recordClass II

Levothroid (levothyroxine sodium tablets, USP), 300 mcg., 100-count bottles, Rx only, NDC 0456-1328-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.

by Lloyd Inc. of Iowa

Reason: cGMP Deviations; does not meet in process specification requirements
Published: December 12, 2012
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: November 14, 2013Historical recordClass II

Thyro-Tab 0.300 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.

by Lloyd Inc. of Iowa

Reason: cGMP Deviations; does not meet in process specification requirements
Published: December 12, 2012
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: November 14, 2013Historical recordClass II

Levothroid (levothyroxine sodium tablets, USP), 137 mcg., 100-count bottles, Rx only, NDC 0456-1331-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.

by Lloyd Inc. of Iowa

Reason: cGMP Deviations; does not meet in process specification requirements
Published: December 12, 2012
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: November 14, 2013Historical recordClass II

Thyro-Tab 0.137 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.

by Lloyd Inc. of Iowa

Reason: cGMP Deviations; does not meet in process specification requirements
Published: December 12, 2012
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: November 14, 2013Historical recordClass II

Levothroid (levothyroxine sodium tablets, USP),125 mcg., 100-count bottles, Rx only, NDC 0456-1324-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.

by Lloyd Inc. of Iowa

Reason: cGMP Deviations; does not meet in process specification requirements
Published: December 12, 2012
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: November 14, 2013Historical recordClass II

Thyro-Tab 0.125 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.

by Lloyd Inc. of Iowa

Reason: cGMP Deviations; does not meet in process specification requirements
Published: December 12, 2012
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: November 14, 2013Historical recordClass II

Levothroid (levothyroxine sodium tablets, USP), 112 mcg., 100-count bottles, Rx only, NDC 0456-1330-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.

by Lloyd Inc. of Iowa

Reason: cGMP Deviations; does not meet in process specification requirements
Published: December 12, 2012
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: November 14, 2013Historical recordClass II

Thyro-Tab 0.112 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.

by Lloyd Inc. of Iowa

Reason: cGMP Deviations; does not meet in process specification requirements
Published: December 12, 2012
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: November 14, 2013Historical recordClass II

Levothroid (levothyroxine sodium tablets, USP), 88 mcg., 100-count bottles, Rx only, NDC 0456-1329-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.

by Lloyd Inc. of Iowa

Reason: cGMP Deviations; does not meet in process specification requirements
Published: December 12, 2012
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: November 14, 2013Historical recordClass II

Thyro-Tab 0.088 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.

by Lloyd Inc. of Iowa

Reason: cGMP Deviations; does not meet in process specification requirements
Published: December 12, 2012
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: November 14, 2013Historical recordClass II

Levothroid (levothyroxine sodium tablets, USP), 50 mcg., 100-count bottles, Rx only, NDC 0456-1321-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.

by Lloyd Inc. of Iowa

Reason: cGMP Deviations; does not meet in process specification requirements
Published: December 12, 2012
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: November 14, 2013Historical recordClass II

Thyro-Tab 0.050 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.

by Lloyd Inc. of Iowa

Reason: cGMP Deviations; does not meet in process specification requirements
Published: December 12, 2012
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: May 30, 2014Historical recordClass III

Novarel¿ (Chorionic Gonadotropin for injection, USP), 10,000 USP FOR INTRAMUSCULAR USE ONLY Rx Only NDC 55566-1501-0 Manufactured for : Ferring Pharmaceuticals Inc., Parsippany, NJ 07054 Manufactured by: DRAXIS Specialty Pharmaceuticals Inc., Quebec, Canada. NDC # 55566-1501-0 is assigned to the vial of NOVAREL and is displayed on the vial label. NDC # 55566-1501-1 is assigned to the unit of sale, which is a carton containing 1 vial of NOVAREL and 1 vial of diluent along with the insert. NDC # 55566-1501-1 is displayed on the unit of sale and is the item subject to recall.

by Ferring Pharmaceuticals Inc

Reason: Labeling; incorrect or missing insert; Warnings portion of the Package Insert is missing the warning statement: Anaphylaxis has been reported with urinary-derived hCG products.
Published: December 12, 2012
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: April 28, 2014Historical recordClass II

Atorvastatin Calcium Tablets, 40 mg, a) 90 tablets per bottle, b) 500 tablets per bottle, Rx only, Manufactured for: Ranbaxy Pharmaceuticals Inc., Jacksonville, FL 32257, USA, by: Ranbaxy Laboratories Ltd., New Delhi - 110019, India, NDC #: a) 63304-829-90, b) 63304-829-05.

by Ranbaxy Inc.

Reason: Presence of Particulate Matter: Certain batches of Atorvastatin tablets 10 mg, 20 mg and 40 mg may contain small glass particulates.
Published: December 5, 2012
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: April 28, 2014Historical recordClass II

Atorvastatin Calcium Tablets, 20 mg, 90 tablets per bottle, Rx only, Manufactured for: Ranbaxy Pharmaceuticals Inc., Jacksonville, FL 32257, USA, by: Ranbaxy Laboratories Ltd., New Delhi - 110019, India, NDC #: 63304-828-90

by Ranbaxy Inc.

Reason: Presence of Particulate Matter: Certain batches of Atorvastatin tablets 10 mg, 20 mg and 40 mg may contain small glass particulates.
Published: December 5, 2012
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: April 28, 2014Historical recordClass II

Atorvastatin Calcium Tablets, 10 mg, 90 tablets per bottle, Rx only, Manufactured for: Ranbaxy Pharmaceuticals Inc., Jacksonville, FL 32257, USA, by: Ranbaxy Laboratories Ltd., New Delhi - 110019, India, NDC #: 63304-827-90

by Ranbaxy Inc.

Reason: Presence of Particulate Matter: Certain batches of Atorvastatin tablets 10 mg, 20 mg and 40 mg may contain small glass particulates.
Published: December 5, 2012
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: December 23, 2013Historical recordClass II

Vicks NyQuil Cold & Flu, Nighttime Relief, 12 FL OZ bottle, Dist. by Proctor and Gamble, Cincinnati, OH 45040. NDC 37000-808-12

by Procter & Gamble Co

Reason: Labeling Illegible: Portions of the product labeling in the area of the dosing directions, the warnings & other information sections is obscured.
Published: December 5, 2012
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: September 11, 2014Historical recordClass II

Arranon (nelarabine) Injection 5mg/mL, 50mL Vials, Rx only, For I.V. Infusion only, GlaxoSmith Kline, Research Triangle Park, NC 27709. Made in England, NDC 0007-4401-06

by GlaxoSmithKline, LLC.

Reason: Impurities/Degradation Products: Potential for drug related impurities to exceed the specification limits.
Published: December 5, 2012
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: September 18, 2013Historical recordClass II

Pradaxa (dabigatran etexilate), 75 mg Capsules, 60 count bottles, Rx only, Distributed by Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT --- NDC 0597-0149-54

by Boehringer Ingelheim Roxane Inc

Reason: Defective container; damaged bottles could allow moisture to get into the bottle and thus may impair the quality of the product
Published: December 5, 2012
Distribution: Nationwide

View recall →

Data last updated: October 8, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.